Coronavirus (SARS CoV-2) anti-viral update August 2020
NanoGuardX antimicrobial coating’s active ingredient is certified to kill the TGEV Coronavirus and Influenza A viruses upon surface contact.
The TGEV Coronavirus is the model structure of SARS CoV, and our manufactures are currently in the queue waiting to be tested at one of Europe’s leading test laboratories against SARS-CoV-2 (COVID-19). Such laboratories are currently inundated with work. They are confident that our coating will be found to be effective, and have been advised by a leading independent sanitation specialist accordingly.
We will confirm its certification as soon as we’re able to, and in the meantime we would advise that any coating treatment claiming to offer longer than “momentary” effectiveness against SARS CoV-2 should have its claims thoroughly vetted. We do not know of any products in our category that have been tested against it due to the scarcity of the strain; meaning that it is not available in commercial testing laboratories.
In any case NanoGuardX has been independently verified in it’s effectiveness at killing TGEV Coronavirus, meaning that ourselves and our manufacturers are extremely confident that it is SARS CoV-2 effective. Furthermore, it’s effectiveness against Influenza A, Klebsiella pneumoniae (Pneumonia) and many more bacterial microbes, confirms its valuable contribution to continually reducing the chances of co-infection from surfaces alongside SARS CoV-2. It’s the co-infection risk that can place those most prone in society (with underlying health conditions) who contract the disease at the greatest risk.